Skip to content

Current product clinical summary

EyeCrème — current eight-week clinical summary

The current EyeCrème product page reports an eight-week independent clinical study evaluating eye-area radiance and wrinkle appearance, plus a separate consumer study and ophthalmologist-tested contact-lens-wearer suitability.

maintained by Alan Kante · owner, SeneGence International · verified 2026-07-10

Source
Current official US EyeCrème product page, verified July 10, 2026
Last verified
2026-07-10
Method
Expert grading and Visioscan analysis compared with baseline; consumer agreement reported separately
Sample
31 participants
Evidence record scope master. A reusable evidence header with fields for tested article, record type, method, sample, endpoint, duration, result, and qualification.

scoped claims

claim 01

eight-week independent clinical support for visible eye-area radiance and wrinkle appearance

An eight-week independent clinical study of current EyeCrème supports visible eye-area radiance and wrinkle appearance.

Scope
current EyeCrème finished product; separate from SeneDerm Eye Creme AGE Defense records
Endpoint
visible eye-area radiance and wrinkle appearance
Duration
8 weeks

claim 02

ophthalmologist-tested and suitable for contact-lens wearers

Current EyeCrème is ophthalmologist-tested and described as safe for contact-lens wearers.

Scope
current EyeCrème finished product; separate from SeneDerm Eye Creme AGE Defense records
Endpoint
eye-area and contact-lens-wearer suitability
Duration
current product safety statement

qualification

what can this evidence support?

This record applies only to the named source, claim scope, endpoint, method, sample, and duration.

  1. →The Clinical Filelearn

questions this evidence answers

  1. ?What does SeneGence EyeCrème do?answer